PRIMROSE THERAPEUTICS
Primrose Therapeutics, Inc. is a biotechnology company focused on the development of treatments for Polycystic Kidney Disease (PKD). PKD is one of the most common life-threatening genetic disorders, affecting 600,000 Americans and 12.5 million people worldwide -- more than cystic fibrosis, muscular dystrophy, hemophilia, Down syndrome and sickle cell anemia combined. PKD results in the abnormal growth of cells in the kidney, which eventually lead to the development of bilateral kidney cysts and structural destruction of the kidney. The average lifespan of PKD patients is 64 years -- at least a decade shorter than average. No FDA approved therapies currently exist for this devastating disease.
PRIMROSE THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2010-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.primrosetherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
212-632-5404
Email Addresses:
[email protected]
Total Funding:
752.55 K USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Chatham Therapeutics
Chatham Therapeutics is engaged in the development of gene-based therapy technologies focused on hemophilia.
Renovar
Renovar is engaged in the development of diagnostic tests for the treatment of kidney diseases.
Sarentis Therapeutics
Sarentis Therapeutics engages in the development of therapeutics for the treatment of pain.
WRS Therapeutics
WRS Therapeutics is targeting the multi-billion dollar injectables market with large molecule drugs delivered orally.
Current Employees Featured
Founder
Official Site Inspections
http://www.primrosetherapeutics.com
Unable to get host informations!!!
More informations about "Primrose Therapeutics"
Primrose Therapeutics - Crunchbase Company Profile & Funding
Primrose Therapeutics, Inc. is a biotechnology company focused on the development of treatments for Polycystic Kidney Disease (PKD). PKD is one of the most common life …See details»
Primrose Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Primrose Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Primrose Therapeutics - Company Profile - Tracxn
Primrose Therapeutics ranks 99th among 112 active competitors. 43 of its competitors are funded while 37 have exited. Overall, Primrose Therapeutics and its competitors have raised over …See details»
Primrose Therapeutics - PitchBook
Primrose Therapeutics is a Private company. What is Primrose Therapeutics’s current revenue? The current revenue for Primrose Therapeutics is . How much funding has Primrose …See details»
Primrose Therapeutics - Company Profile & Staff Directory
Primrose Therapeutics, Inc. is a biotechnology company focused on the development of treatments for Polycystic Kidney Disease (PKD). PKD is one of the most common life …See details»
Primrose Therapeutics - Craft
Primrose Therapeutics is engaged in the development of treatments for polycystic kidney disease. PKD is one of the most common life-threatening genetic disorders which results in the …See details»
Primrose Therapeutics - Products, Competitors, Financials, …
Primrose Therapeutics is a biotechnology company focused on developing therapies for the treatment of polycystic kidney disease. Use the CB Insights Platform to explore Primrose …See details»
PRIMROSE THERAPEUTICS, INC. Top 13F Holdings
PRIMROSE THERAPEUTICS, INC. 875 THIRD AVENUE NEW YORK NY 10022 Business Phone: 212-632-5404. Recent SEC Filings. Filing Date; We give you the access and tools to …See details»
Primrose Therapeutics Corporate Headquarters, Office Locations
Primrose Therapeutics Headquarters and Office Locations. Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit. Button CTA. Primrose Therapeutics is headquartered in …See details»
Primrose Therapeutics, Inc.:Company Profile & Technical Research ...
Primrose Therapeutics is headquartered in United States New York. Primrose Therapeutics was founded in 2010. Related Topics. Health care Pharmacy and Therapeutics Kidney Polycystic …See details»
Primrose Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 17, 2010: Seed Round - …See details»
Our Team - Primrose Bio, Inc.
CFO | Simon Latimer Simon oversees the finance and accounting functions at Primrose Bio. Prior to joining Primrose, he was the head of corporate development and investor relations at …See details»
Primrose Therapeutics - Contacts, Employees, Board Members
Organization. Primrose Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. …See details»
Primrose Therapeutics - Products, Competitors, Financials, …
Headquarters Location. 875 Third Avenue 3rd Floor. New York, New York, 10022, United States (212)632-5404See details»
About Us - Primrose Bio, Inc.
As a fully integrated CMC organization, we’re suited to ensure your success. LEADERSHIP. Board & ADVISORS. Our Heritage. We have established more than 100 collaborations, …See details»
Primrosetherapeutics Cyber Security Rating & Vendor Risk Report ...
Primrose Therapeutics is engaged in the development of treatments for polycystic kidney disease. PKD is one of the most common life-threatening genetic disorders which results in the …See details»
Primrose Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. Primrose Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 1. About. …See details»
Primrose Bio Announces Investment from 1315 Capital to Advance ...
Jun 17, 2024 "We are thrilled to have the support of such a high-quality organization and team at 1315 Capital who share our vision of expanding opportunities in biomanufacturing …See details»
Introducing Primrose Bio: Enabling Innovative Therapeutic …
Sep 18, 2023 /PRNewswire/ -- Primrose Bio, Inc., a stand-alone private biotechnology company focused on developing state-of-the-art discovery and production systems for...See details»
Primrose Bio Announces Investment from 1315 Capital to Advance ...
Jun 17, 2024 Primrose Bio, Inc. (“Primrose,” the “Company”), a company focused on developing and licensing its manufacturing technologies for nucleic acids and proteins used in …See details»